CIC
GILD icon

Crawford Investment Counsel’s Gilead Sciences GILD Stock Holding History

Crawford Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2M Sell
17,416
-114
-0.7% -$15K 0.04% 190
2026
Q1 		$2.44M Sell
17,530
-8,013
-31% -$1.12M 0.04% 185
2025
Q4 		$3.14M Sell
25,543
-4,648
-15% -$565K 0.05% 178
2025
Q3 		$3.35M Sell
30,191
-96,262
-76% -$10.9M 0.06% 170
2025
Q2 		$14M Sell
126,453
-22,943
-15% -$2.44M 0.24% 89
2025
Q1 		$16.7M Sell
149,396
-175,441
-54% -$18.1M 0.3% 80
2024
Q4 		$30M Sell
324,837
-14,156
-4% -$1.27M 0.54% 49
2024
Q3 		$28.4M Sell
338,993
-4,761
-1% -$363K 0.49% 55
2024
Q2 		$23.6M Buy
343,754
+15,699
+5% +$1.05M 0.45% 59
2024
Q1 		$24M Buy
328,055
+3,633
+1% +$279K 0.45% 60
2023
Q4 		$26.3M Sell
324,422
-48,843
-13% -$3.8M 0.53% 52
2023
Q3 		$28M Buy
373,265
+3,146
+0.8% +$242K 0.61% 47
2023
Q2 		$28.5M Buy
370,119
+75,284
+26% +$6M 0.58% 47
2023
Q1 		$24.5M Sell
294,835
-29,933
-9% -$2.48M 0.52% 54
2022
Q4 		$27.9M Sell
324,768
-21,165
-6% -$1.68M 0.6% 47
2022
Q3 		$21.3M Buy
345,933
+12,672
+4% +$799K 0.5% 52
2022
Q2 		$20.6M Buy
+333,261
New +$20.6M 0.46% 56

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Crawford Investment Counsel's GILD Position: Q2 2026 in Review

Crawford Investment Counsel reduced its Gilead Sciences (GILD) stake by 0.65% in Q2 2026, selling an estimated $15K and leaving 17,416 shares worth $2.2M. The position accounts for 0.04% of the portfolio, ranked #190.

Crawford Investment Counsel first reported a position in GILD in Q2 2022 and has held it in 17 quarters since. The position peaked at $30M in Q4 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Crawford Investment Counsel held 17,416 shares of Gilead Sciences worth $2.2M as of Q2 2026.
  • Crawford Investment Counsel sold 114 Gilead Sciences shares in Q2 2026, an estimated $15K.
  • Gilead Sciences made up 0.04% of Crawford Investment Counsel's portfolio in Q2 2026, its #190 holding.
  • Crawford Investment Counsel first reported a position in Gilead Sciences in Q2 2022 and has held it in 17 quarters since.
  • Crawford Investment Counsel's Gilead Sciences position peaked at $30M in Q4 2024.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Crawford Investment Counsel's 13F filing for Q2 2026, filed 14 Aug 2026.